Skip to main content
Top
Published in: Clinical Rheumatology 4/2021

01-04-2021 | Systemic Sclerosis | Original Article

Cultural adaptation and validation of the Systemic Sclerosis Quality of Life questionnaire into Arabic language

Authors: Samah M Alian, Nagwa A Sherby, Shymaa A Sarhan

Published in: Clinical Rheumatology | Issue 4/2021

Login to get access

Abstract

Background and objectives

Systemic sclerosis (SSc) is a chronic connective tissue disease affecting all quality of life (QoL) parameters. In addition to clinical assessment, QoL measures should be included in patient assessment. There is no Arabic tool specific for assessing QoL in Arabic SSc patients; therefore, this work was designed to translate the SScQoL questionnaire, culturally adapt and check its reliability and validity.

Method

Based on the principle of translation and cross-cultural adaptation in other language, the SScQoL questionnaire was translated into Arabic. Correlation of SScQoL scores for 50 patients with Short Form Health Survey (SF-36) scores has been tested for convergent validity and discriminate validity evaluated by stratifying clinical parameters of patients and disease subtypes. The intraclass correlation coffee (ICC) was used to assess reliability by interviewing patients twice 14 days apart.

Results

Correlations were present between SScQoL scores and physical and mental component scores of SF-36 questionnaire. We found strong negative correlation between the physical component of SF-36 and QoL function, QoL emotion, QoL total scores (r = − 0.654**, r = − 0.512**, r = − 0.540**) and moderate negative correlation present between SF-36 mental component and QoL function, QoL emotion, QoL social, and QoL total (r = − 0.314*, r = − 0.486**, r = − 0.357*, r = − 0.433*). Also, significant association (P < 0.05*) between scores of total QoL and visceral involvements (GIT involvement, pericardial effusion, and LVDD) was evident. The Arabic edition of SScQoL has a Cronbach’s alpha of 0.78.

Conclusion

The translated Arabic version is a valid and reliable tool to assess Egyptian SSc patients’ QoL.
Key Points
The SScQoL questionnaire items have a convergent validity with physical and mental component scores of SF-36, and discriminant validity with visceral involvement.
The Arabic edition of SScQoL is reliable with a Cronbach’s alpha of 0.78.
Literature
2.
go back to reference Denton CP, Khanna D (2017) Systemic sclerosis. Lancet 390(10103):1685–1699CrossRef Denton CP, Khanna D (2017) Systemic sclerosis. Lancet 390(10103):1685–1699CrossRef
3.
go back to reference Tugwell P, Boers M, Brooks P, Simon L, Strand V, Idzerda L (2007) OMERACT: an international initiative to improve outcome measurement in rheumatology. Trials 8(1):38CrossRef Tugwell P, Boers M, Brooks P, Simon L, Strand V, Idzerda L (2007) OMERACT: an international initiative to improve outcome measurement in rheumatology. Trials 8(1):38CrossRef
4.
go back to reference Strickland G, Pauling J, Cavill C, McHugh N (2012) Predictors of health-related quality of life and fatigue in systemic sclerosis: evaluation of the EuroQoL-5D and FACIT-F assessment tools. Clin Rheumatol 31(8):1215–1222CrossRef Strickland G, Pauling J, Cavill C, McHugh N (2012) Predictors of health-related quality of life and fatigue in systemic sclerosis: evaluation of the EuroQoL-5D and FACIT-F assessment tools. Clin Rheumatol 31(8):1215–1222CrossRef
5.
go back to reference Sierakowska M, Sierakowski S, Olesinska M, Brzosko M, Leszczynski P, Pawlak-Bus K, Batko B, Wiland P, Majdan M, Bykowska-Sochacka M (2017) Systemic Sclerosis Quality of Life Questionnaire (SScQoL) captures the complex problems experienced by patients with scleroderma. In: Arthritis & rheumatology. Wiley, Hoboken Sierakowska M, Sierakowski S, Olesinska M, Brzosko M, Leszczynski P, Pawlak-Bus K, Batko B, Wiland P, Majdan M, Bykowska-Sochacka M (2017) Systemic Sclerosis Quality of Life Questionnaire (SScQoL) captures the complex problems experienced by patients with scleroderma. In: Arthritis & rheumatology. Wiley, Hoboken
6.
go back to reference Reay N (2008) The quality of life in patients with diffuse and limited systemic sclerosis. University of Leeds Reay N (2008) The quality of life in patients with diffuse and limited systemic sclerosis. University of Leeds
7.
go back to reference Van Den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE (2013) 2013 Classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 65(11):2737–2747CrossRef Van Den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE (2013) 2013 Classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 65(11):2737–2747CrossRef
8.
go back to reference Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, Weinstein A, Weisman M, Mayes M, Collier D (1995) Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 22(7):1281–1285PubMed Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, Weinstein A, Weisman M, Mayes M, Collier D (1995) Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 22(7):1281–1285PubMed
9.
go back to reference LeRoy EC (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed LeRoy EC (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed
10.
go back to reference Ndosi M, Alcacer-Pitarch B, Allanore Y, Del Galdo F, Frerix M, García-Díaz S, Hesselstrand R, Kendall C, Matucci-Cerinic M, Mueller-Ladner U (2018) Common measure of quality of life for people with systemic sclerosis across seven European countries: a cross-sectional study. Ann Rheum Dis 77(7):1032–1038CrossRef Ndosi M, Alcacer-Pitarch B, Allanore Y, Del Galdo F, Frerix M, García-Díaz S, Hesselstrand R, Kendall C, Matucci-Cerinic M, Mueller-Ladner U (2018) Common measure of quality of life for people with systemic sclerosis across seven European countries: a cross-sectional study. Ann Rheum Dis 77(7):1032–1038CrossRef
11.
12.
go back to reference Beaton DE, Bombardier C, Guillemin F, Ferraz MB (2000) Guidelines for the process of cross-cultural adaptation of self-report measures. Spine 25(24):3186–3191CrossRef Beaton DE, Bombardier C, Guillemin F, Ferraz MB (2000) Guidelines for the process of cross-cultural adaptation of self-report measures. Spine 25(24):3186–3191CrossRef
13.
go back to reference Fayers PM, Machin D (2013) Quality of life: the assessment, analysis and interpretation of patient-reported outcomes. Wiley Fayers PM, Machin D (2013) Quality of life: the assessment, analysis and interpretation of patient-reported outcomes. Wiley
14.
15.
go back to reference Häuser W, Zimmer C, Schiedermaier P, Grandt D (2004) Biopsychosocial predictors of health-related quality of life in patients with chronic hepatitis C. Psychosom Med 66(6):954–958CrossRef Häuser W, Zimmer C, Schiedermaier P, Grandt D (2004) Biopsychosocial predictors of health-related quality of life in patients with chronic hepatitis C. Psychosom Med 66(6):954–958CrossRef
16.
go back to reference Sierakowska M, Sierakowski S, Sierakowska J, Horton M, Ndosi M (2015) Developing the Polish Educational Needs Assessment Tool (Pol-ENAT) in rheumatoid arthritis and systemic sclerosis: a cross-cultural validation study using Rasch analysis. Qual Life Res 24(3):721–733CrossRef Sierakowska M, Sierakowski S, Sierakowska J, Horton M, Ndosi M (2015) Developing the Polish Educational Needs Assessment Tool (Pol-ENAT) in rheumatoid arthritis and systemic sclerosis: a cross-cultural validation study using Rasch analysis. Qual Life Res 24(3):721–733CrossRef
17.
go back to reference Kulikowski K (2014) Quality of life in the context of psychology and medicine. Reumatologia 52(3):200CrossRef Kulikowski K (2014) Quality of life in the context of psychology and medicine. Reumatologia 52(3):200CrossRef
18.
go back to reference Cruz-Domínguez MP, Casarrubias-Ramírez M, Gasca-Martínez V, García CM, Carranza-Muleiro RA, Medina G, García-Collinot G, Montes-Cortes DH (2019) The Systemic Sclerosis Questionnaire (SySQ): validation of the translation of the original German version into Spanish and its relationship to the disease and to quality of life. Reumatol Clín (Engl Ed) 15(5):282–288CrossRef Cruz-Domínguez MP, Casarrubias-Ramírez M, Gasca-Martínez V, García CM, Carranza-Muleiro RA, Medina G, García-Collinot G, Montes-Cortes DH (2019) The Systemic Sclerosis Questionnaire (SySQ): validation of the translation of the original German version into Spanish and its relationship to the disease and to quality of life. Reumatol Clín (Engl Ed) 15(5):282–288CrossRef
19.
go back to reference Ng X, Thumboo J, Low AH (2012) Validation of the scleroderma health assessment questionnaire and quality of life in English and Chinese-speaking patients with systemic sclerosis. Int J Rheum Dis 15(3):268–276CrossRef Ng X, Thumboo J, Low AH (2012) Validation of the scleroderma health assessment questionnaire and quality of life in English and Chinese-speaking patients with systemic sclerosis. Int J Rheum Dis 15(3):268–276CrossRef
Metadata
Title
Cultural adaptation and validation of the Systemic Sclerosis Quality of Life questionnaire into Arabic language
Authors
Samah M Alian
Nagwa A Sherby
Shymaa A Sarhan
Publication date
01-04-2021
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 4/2021
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05373-0

Other articles of this Issue 4/2021

Clinical Rheumatology 4/2021 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.